查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
生物製药第三方物流市场规模、份额和趋势分析报告：按供应链、按服务类型、按地区和细分趋势：2023-2030
市场调查报告书
商品编码
1321325

生物製药第三方物流市场规模、份额和趋势分析报告：按供应链、按服务类型、按地区和细分趋势：2023-2030

Biopharmaceutical Third-party Logistics Market Size, Share & Trends Analysis Report By Supply Chain (Cold Chain, Non-cold Chain), By Service Type (Transportation, Warehousing & Storage), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

生物製药 3PL 市场增长和趋势

Grand View Research, Inc.最新报告显示，到2030年，全球生物製药第三方物流（3PL）市场预计将达到1985亿美元。

预计 2023 年至 2030 年该市场将以 6.0% 的年复合成长率扩张。对跨地区运输生物製剂的温控物流服务的需求不断增长，以及生物製药公司扩大分销网络以增加销售队伍，正在推动市场增长，这是一个促进因素。新兴国家越来越多地采用自动化存储和搜寻系统是医药物流公司的持续趋势，并且正在获得巨大的吸引力。

此外，市场预计将受到从小分子药物向生物製药（主要是疫苗和生物製剂）转型趋势的推动。由于这些小分子药物是温度敏感产品，对温控运输和储存的需求不断增加，这是市场增长的一个因素。技术进步是推动市场增长的主要因素之一。移动云解决方案、仓库机器人和资料挖掘等技术已经改变了整个 3PL 领域。借助这些先进技术，3PL 公司能够在运输过程中保持产品所需的温度。

这降低了产品复杂性和人为错误。大多数生物药品对温度非常敏感，必须在要求的温度下储存。此类产品需要跟踪设备进行监控直至交付。例如，2023年5月，Tridentify推出了具有创新能力的实时冷链监控系统，能够持续跟踪冷链上运输的产品的稳定性和剩余保质期。该系统将通过提供对药物稳定性和剩余保质期的实时、详细洞察，彻底改变公司监控运营和管理稳定性预算的方式。

此外，出于环境考虑和成本考虑，商业产品的运输方式正逐渐从空运转向海运，从道路运输转向多式联运（铁路和卡车）。这些製药公司主要使用多式联运来减少碳排放。持续的趋势表明，製药商正在转向海运以降低成本和风险因素。对于冷链产品，企业还是更青睐航空运输。然而，一些大型製药公司计划通过海运运输其70%的产品，其中包括冷链产品。

生物製药 3PL 市场报告亮点

  • 到2022年，由于无温药品的销售量很大，非冷链物流领域将占销售额的最大份额，达到79.7%。
  • 在细胞疗法、疫苗和检测套组等生物製品需求的推动下，冷链物流领域预计在预测期内年复合成长率8.8%。
  • 仓储业占比最大，2022年为43.3%。由于企业内部能力不足，交通运输行业在 2022 年也占据了很大的收入份额。
  • 由于生物製药进出口增加，2022 年北美地区收入占比最大，超过 42%。
  • 由于高龄化以及药品销售从品牌製造商转向非专利製造商的转变，亚太地区预计在预测期内年复合成长率为 7.4%。
  • 主要企业正在采取多项战略倡议来提高其在市场上的影响力。例如，2021年2月，德迅与中国最大的非国有药品分销商九州通建立合作伙伴关係，以加强其在中国的医疗保健和药品物流业务。

目录

第1章调查方法和范围

  • 市场区隔和范围
  • 调查方法
  • 资讯或资料分析
  • 调查方法
  • 调查范围和先决条件
  • 市场形成和检验
  • 国家/地区分部份额计算
  • 资料来源列表

第2章执行摘要

第3章生物製药第三方物流市场变量、趋势和范围

  • 市场谱系预测
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 生物製药第三方物流市场分析工具
    • 行业分析-波特
    • PESTEL分析

第4章生物製药第三方物流市场：服务类型估算及趋势分析

  • 分段仪表板
  • 生物製药第三方物流市场：服务变化分析，十亿美元，2022 年和 2030 年
  • 交通设施
    • 2018-2030年交通运输市场收入估算和预测
    • 空运货物
    • 海运
    • 陆运
  • 仓储及保管
    • 2018-2030 年仓储市场收入估算和预测
  • 其他的
    • 2018-2030 年其他市场收入估计和预测

第5章生物製药第三方物流市场：供应链估算与趋势分析

  • 分段仪表板
  • 生物製药第三方物流市场：供应链变化分析，十亿美元，2022 年和 2030 年
  • 新鲜食品的）低温运输系统
    • 2018-2030年冷链市场收入估算及预测
  • 非冷链
    • 2018-2030年非冷链市场收入估算及预测

第6章生物医药第三方物流市场：区域估算与趋势分析

  • 生物製药第三方物流市场：2022年和2030年区域变化分析
  • 北美
    • 2018-2030年北美医药第三方物流市场估计与预测
    • 法律规范
    • 美国
    • 加拿大
  • 欧洲
    • 2018-2030年欧洲生物製药第三方物流市场估计和预测
    • 法律规范
    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018年至2030年亚太生物製药第三方物流市场估计和预测
    • 法律规范
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 鲷鱼
    • 韩国
  • 拉美
    • 2018-2030年拉丁美洲生物製药第三方物流市场估计和预测
    • 法律规范
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 2018-2030年中东和非洲生物製药第三方物流市场估计与预测
    • 法律规范
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 科威特

第7章竞争形势

  • 公司分类
  • 2022 年公司市场份额分析
  • 主要私营企业名单
  • 战略规划
  • 公司简介/名单
    • DHL International GmbH
    • SF Express
    • United Parcel Service of America, Inc.
    • AmerisourceBergen Corp.
    • DB Schenker
    • Kuehne and Nagel
    • Kerry Logistics Network Ltd.
    • Agility
Product Code: GVR-2-68038-773-5

Biopharmaceutical 3PL Market Growth & Trends

The global biopharmaceutical third-party logistics (3PL) market size is expected to reach USD 198.5 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.0% from 2023 to 2030. Increasing demand for temperature-controlled logistic services to transport biologics in various regions and growing distribution networks of biopharmaceutical companies to improve their sales are factors driving the market growth. The rising adoption of automated storage and retrieval systems in emerging countries is an ongoing trend among pharmaceutical logistics companies that has gained significant traction.

Furthermore, the trend of shifting from small-molecule drugs to biopharmaceuticals, mainly vaccines and biologics, is projected to drive the market. Since, these small molecule drugs are temperature-sensitive products, demand for temperature-controlled transportation and storage increases and thus, is responsible for the market growth. Technological advancements are among the main factors drivingmarket growth. Technologies, such as mobile cloud solutions, warehouse robotics, and data mining, have changed the overall 3PL space. With the help of these advanced technologies, 3PL companies can maintain the required temperatures for products during transportation.

This will help in reducing complexities in products and human errors. Most biopharmaceutical products are very temperature-sensitive and hence should be stored at the required temperatures. These products require a tracking device for monitoring until delivery. For instance, in May 2023, Tridentify launched a real-time cold chain monitoring system with an innovative feature for continuously tracking the stability and remaining shelf life of products transported in the cold chain. It offers a thorough view of the stability and remaining shelf-life of pharmaceutical products in real-time, which will revolutionize the way companies monitor their operations and manage their stability budgets.

In addition, environmental concerns and costs have caused a slight shift in the means of transport used for commercial products, moving from airway to seaway shipping and in roadways from truck to intermodal (both rail and truck) transport. Intermodal transport is majorly used by these pharmaceutical companies to reduce their carbon footprint. The ongoing trend shows that pharmaceutical manufacturers have shifted to sea freight to reduce the cost and risk factors. Although for cold chain products, the companies still prefer air freight. However, some of the large pharmaceutical companies are planning to transport 70% of their products via ocean freight including cold chain products.

Biopharmaceutical 3PL Market Report Highlights

  • In 2022, the non-cold chain logistics segment held the largest share of 79.7% in terms of revenue owing to the sales of a large number of drugs that do not require any temperature control
  • The cold chain logistics segment is expected to register a CAGR of 8.8% over the forecast period owing to the demand for biologics, such as cellular therapies, vaccines, and test kits
  • The warehousing and storage segment held the largest share of 43.3% in 2022. The transportation segment also held a significant revenue share in 2022 due to the lack of internal capabilities of companies
  • North America held the largest revenue share of over 42% in 2022 owing to the rise in imports and exports for biopharmaceutical in the country
  • Asia Pacific is expected to register the fastest CAGR of 7.4% over the forecast period owing to the adoption of medicines from the aging population and the shift of drug sales from brand manufacturers to generic
  • The key players are undertaking several strategic initiatives to strengthen their market presence. For instance, in February 2021, Kuehne+Nagel entered into a partnership with China's largest non-state-owned pharma distribution company, Jointown, to enhance its footprint in healthcare & pharmaceutical logistics in China

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
    • 1.2.1. Information Procurement
  • 1.3. Information or Data Analysis
  • 1.4. Methodology
  • 1.5. Research Scope and Assumptions
  • 1.6. Market Formulation & Validation
    • 1.6.1. COUNTRY MARKET: CAGR CALCULATION
  • 1.7. Country Based Segment Share Calculation
  • 1.8. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional Insights
  • 2.4. Competitive Insights
  • 2.5. Biopharmaceutical Third Party Logistics Market Snapshot
  • 2.6. Biopharmaceutical Third Party Logistics Market Segment Snapshot
  • 2.7. Biopharmaceutical Third Party Logistics Market Competitive Landscape Snapshot

Chapter 3. Biopharmaceutical Third Party Logistics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Biopharmaceutical Third-party Logistics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Biopharmaceutical Third-party Logistics Market: Service Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Biopharmaceutical Third-party Logistics Market: Service Movement Analysis, USD Billion, 2022 & 2030
  • 4.3. Transportation
    • 4.3.1. Transportation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.3.2. Air Freight
      • 4.3.2.1. Air Freight Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.3.3. Sea Freight
      • 4.3.3.1. Sea Freight Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.3.4. Overland Transportation
      • 4.3.4.1. Overland Transportation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.4. Warehousing & Storage
    • 4.4.1. Warehousing & Storage Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.5. Others
    • 4.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Biopharmaceutical Third Party Logistics Market: Supply Chain Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Biopharmaceutical Third Party Logistics Market: Supply Chain Movement Analysis, USD Billion, 2022 & 2030
  • 5.3. Cold Chain
    • 5.3.1. Cold Chain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.4. Non-Cold Chain
    • 5.4.1. Non-Cold Chain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Biopharmaceutical Third Party Logistics Market: Regional Estimates & Trend Analysis

  • 6.1. Biopharmaceutical Third Party Logistics Market: Regional Movement Analysis, 2022 & 2030
  • 6.2. North America
    • 6.2.1. North America Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.2.2. Regulatory Framework
    • 6.2.3. U.S.
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Competitive Scenario
      • 6.2.3.3. U.S. Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.2.4. Canada
      • 6.2.4.1. Key Country Dynamics
      • 6.2.4.2. Competitive Scenario
      • 6.2.4.3. Canada Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.3. Europe
    • 6.3.1. Europe Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.2. Regulatory Framework
    • 6.3.3. UK
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. UK Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.4. Germany
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Germany Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.5. France
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Competitive Scenario
      • 6.3.5.3. France Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.6. Italy
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Competitive Scenario
      • 6.3.6.3. Italy Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.7. Spain
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Competitive Scenario
      • 6.3.7.3. Spain Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.8. Denmark
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Competitive Scenario
      • 6.3.8.3. Denmark Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.9. Sweden
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Competitive Scenario
      • 6.3.9.3. Sweden Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.10. Norway
      • 6.3.10.1. Key Country Dynamics
      • 6.3.10.2. Competitive Scenario
      • 6.3.10.3. Norway Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.2. Regulatory Framework
    • 6.4.3. Japan
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Japan Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.4. China
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. China Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.5. India
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. India Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.6. Australia
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Australia Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.7. Thailand
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Thailand Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.8. South Korea
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Competitive Scenario
      • 6.4.8.3. South Korea Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Latin America
    • 6.5.1. Latin America Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.2. Regulatory Framework
    • 6.5.3. Brazil
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Brazil Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.4. Mexico
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Mexico Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.5. Argentina
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Argentina Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Middle East & Africa
    • 6.6.1. Middle East & Africa Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.2. Regulatory Framework
    • 6.6.3. South Africa
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. South Africa Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.4. Saudi Arabia
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Saudi Arabia Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.5. UAE
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. UAE Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.6. Kuwait
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Kuwait Biopharmaceutical Third Party Logistics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Company Market Share Analysis, 2022
  • 7.3. List of Key Private Players
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. DHL International GmbH
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. SF Express
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. United Parcel Service of America, Inc.
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. AmerisourceBergen Corp.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. DB Schenker
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Kuehne and Nagel
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Kerry Logistics Network Ltd.
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Agility
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 4. Global Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 5. Global Biopharmaceutical Third-party Logistics Market by Region, 2018 - 2030 (USD Billion)
  • Table 6. North America Biopharmaceutical Third-party Logistics Market by Country, 2018 - 2030 (USD Billion)
  • Table 7. North America Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 8. North America Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 9. U.S. Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 10. U.S. Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 11. Canada Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 12. Canada Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 13. Europe Biopharmaceutical Third-party Logistics Market by Country, 2018 - 2030 (USD Billion)
  • Table 14. Europe Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 15. Europe Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 16. Germany Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 17. Germany Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 18. UK Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 19. UK Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 20. France Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 21. France Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 22. Italy Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 23. Italy Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 24. Spain Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 25. Spain Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 26. Denmark Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 27. Denmark Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 28. Sweden Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 29. Sweden Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 30. Norway Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 31. Norway Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 32. Asia Pacific Biopharmaceutical Third-party Logistics Market by Country, 2018 - 2030 (USD Billion)
  • Table 33. Asia Pacific Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 34. Asia Pacific Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 35. China Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 36. China Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 37. Japan Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 38. Japan Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 39. India Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 40. India Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 41. South Korea Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 42. South Korea Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 43. Australia Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 44. Australia Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 45. ThailandBiopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 46. ThailandBiopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 47. Latin America Biopharmaceutical Third-party Logistics Market by Country, 2018 - 2030 (USD Billion)
  • Table 48. Latin America Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 49. Latin America Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 50. Brazil Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 51. Brazil Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 52. Mexico Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 53. Mexico Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 54. Argentina Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 55. Argentina Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 56. Middle East & Africa Biopharmaceutical Third-party Logistics Market by Country, 2018 - 2030 (USD Billion)
  • Table 57. Middle East & Africa Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 58. Middle East & Africa Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 59. South Africa Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 60. South Africa Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 61. Saudi Arabia Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 62. Saudi Arabia Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 63. UAE Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 64. UAE Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
  • Table 65. Kuwait Biopharmaceutical Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
  • Table 66. Kuwait Biopharmaceutical Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Primary Research Pattern
  • Fig. 2 Market Research Approaches
  • Fig. 3 Value Chain-Based Sizing & Forecasting
  • Fig. 4 Market Formulation & Validation
  • Fig. 5 Biopharmaceutical Third-party Logistics Market, Market Segmentation
  • Fig. 6 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 7 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 9 Penetration & Growth Prospect Mapping
  • Fig. 10 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 Market Penetration Vs Growth Prospect Mapping, 2021
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Global Biopharmaceutical Third-party Logistics Market for Cold chain, 2018 - 2030 (USD Billion)
  • Fig. 15 Global Biopharmaceutical Third-party Logistics Market for Non-cold chain, 2018 - 2030 (USD Billion)
  • Fig. 16 Global Biopharmaceutical Third-party Logistics Market for Transportation, 2018 - 2030 (USD Billion)
  • Fig. 17 Global Biopharmaceutical Third-party Logistics Market for Air freight, 2018 - 2030 (USD Billion)
  • Fig. 18 Global Biopharmaceutical Third-party Logistics Market for Sea freight, 2018 - 2030 (USD Billion)
  • Fig. 19 Global Biopharmaceutical Third-party Logistics Market for Overland transportation, 2018 - 2030 (USD Billion)
  • Fig. 20 Global Biopharmaceutical Third-party Logistics Market for Warehousing and storage, 2018 - 2030 (USD Billion)
  • Fig. 21 Global Biopharmaceutical Third-party Logistics Market for Others, 2018 - 2030 (USD Billion)
  • Fig. 22 Regional Outlook, 2021 & 2030
  • Fig. 23 North America Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 24 U.S. Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 25 Canada Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 26 Europe Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 27 Germany Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 28 UK Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 29 France Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 30 Italy Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 31 Spain Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 32 Denmark Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 33 Sweden Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 34 Norway Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 35 Asia Pacific Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 36 Japan Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 37 China Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 38 India Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 39 Australia Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 40 South Korea Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 41 Thailand Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 42 Latin America Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 43 Brazil Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 44 Mexico Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 45 Argentina Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 46 Middle East and Africa Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 47 South Africa Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 48 Saudi Arabia Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 49 UAE Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)
  • Fig. 50 Kuwait Biopharmaceutical Third-party Logistics Market, 2018 - 2030 (USD Billion)